<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">875278</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2022.875278</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Three-Dimensional Poly-(&#x3b5;-Caprolactone) Nanofibrous Scaffolds Promote the Maturation of Human Pluripotent Stem Cells-Induced Cardiomyocytes</article-title>
<alt-title alt-title-type="left-running-head">Zhang et al.</alt-title>
<alt-title alt-title-type="right-running-head">Nanofibrous Scaffolds Promote iPSC-CMs Maturation</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Mingming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/984239/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Yuerong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Qinru</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xiaoli</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ding</surname>
<given-names>Lu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Ting</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zeng</surname>
<given-names>Di</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Cardiology</institution>, <institution>Tangdu Hospital</institution>, <institution>the Fourth Military Medical University</institution>, <addr-line>Xi&#x2019;an</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Orthodontics</institution>, <institution>School of Stomatology</institution>, <institution>the Fourth Military Medical University</institution>, <addr-line>Xi&#x2019;an</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Cardiology</institution>, <institution>971th Hospital</institution>, <institution>Chinese People&#x2019;s Liberation Army Navy</institution>, <addr-line>Qingdao</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Neurological Rehabilitation</institution>, <institution>Xi &#x2018;an International Medical Center Hospital</institution>, <addr-line>Xi&#x2019;an</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1003934/overview">Yifei Li</ext-link>, Sichuan University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/850588/overview">Hong Guo</ext-link>, Army Medical University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1526687/overview">Xujie Liu</ext-link>, Chinese Academy of Medical Sciences and Peking Union Medical College, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/854369/overview">Xiaoling Guo</ext-link>, Wenzhou Medical University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Di Zeng, <email>dilal6891@163.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Signaling, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>08</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>875278</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Zhang, Xu, Chen, Yan, Li, Ding, Wei and Zeng.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhang, Xu, Chen, Yan, Li, Ding, Wei and Zeng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Although pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have been proved to be a new platform for heart regeneration, the lack of maturity significantly hinders the clinic application. Recent researches indicate that the function of stem cell is associated with the nanoscale geometry/topography of the extracellular matrix (ECM). However, the effects of 3D nanofibrous scaffolds in maturation of iPSC-CMs still remain unclear. Thus, we explored the effects of restructuring iPSC-CMs in 3D nano-scaffolds on cell morphology, cardiac-specific structural protein, gap junction and calcium transient kinetics. Using the electrospinning technology, poly-(&#x3b5;-caprolactone) (PCL) nanofibrous scaffold were constructed and iPSC-CMs were seeded into these forms. As expected, strong sarcolemmal remodeling processes and myofilament reorientation were observed in 3D nano-scaffolds culture, as well as more expression of cardiac mature proteins, such as &#x3b2;-MHC and MLC2v. The mature morphology of 3D-shaped iPSC-CMs leaded to enhanced calcium transient kinetics, with increased calcium peak transient amplitude and the maximum upstroke velocity (Vmax). The results revealed that the maturation of iPSC-CMs was enhanced by the electrospun 3D PCL nanofibrous scaffolds treatment. These findings also proposed a feasible strategy to improve the myocardium bioengineering by combining stem cells with scaffolds.</p>
</abstract>
<kwd-group>
<kwd>nanofibrous scaffolds</kwd>
<kwd>electrospinning</kwd>
<kwd>cardiomyocytes maturation</kwd>
<kwd>extracellular matrix</kwd>
<kwd>induced pluripotent stem cell</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>iPSC-CMs have enormous potential for the heart regeneration and drug screening in clinic. The differentiation efficiency had been improved in recent years (<xref ref-type="bibr" rid="B12">Karbassi et al., 2020a</xref>). However, the morphology, physiological function and electrophysiological characteristics of iPSC-CMs are still immature compared to adult cardiomyocytes (CMs). The iPSC-CM are composed of immature ventricles, atria, and pacemaker cells, which are not suitable for heart disease modeling and drug screening in specific cardiomyocyte subtypes. Moreover, there are potential safety risk of teratoma and arrhythmia after <italic>in vivo</italic> transplantation of iPSC-CMs due to the poor functional mecha-electrical coupling between iPSC-CMs and <italic>in vivo</italic> cardiomyocytes (<xref ref-type="bibr" rid="B18">Liu et al., 2018</xref>). Therefore, it is urgent to explore a more applicable strategy for iPSC-CM maturation, which is closer to the electrophysiological and mechanical properties of adult cardiomyocytes.</p>
<p>Numerous approaches to promote iPSC-CMs maturation have been explored, including prolonging the time of cell culture (<xref ref-type="bibr" rid="B24">Sartiani et al., 2017</xref>), metabolic hormonal treatment (<xref ref-type="bibr" rid="B21">Parikh et al., 2017</xref>), substrate stiffness (<xref ref-type="bibr" rid="B5">Feaster et al., 2015</xref>), and tissue engineering (<xref ref-type="bibr" rid="B23">Ronaldson-Bouchard et al., 2018</xref>). However, it is still necessary to improve the iPSC-CMs maturation because of the insufficient maturation based on these approaches. The maturation of cardiomyocytes is a complex process, which is unlikely to be dominated and controlled by a single pathway. For this reason, the combination of multiple methods to better mimic the maturation microenvironment of natural myocardium is expected to promote the maturation of iPSC-CMs. Currently, ECM is the most ideal appropriate combination carrier, since it can shape different biomechanical properties using various methods such as matrix stiffness modulation, micro-patterning and 3D culture (<xref ref-type="bibr" rid="B9">Herron et al., 2016</xref>) to affect the maturation of cardiomyocytes (<xref ref-type="bibr" rid="B10">Huang et al., 2020</xref>). Our previous study also found that the biomimetic microenvironment established by 3D matrix culture can promote the directed differentiation of iPSC-CMs (<xref ref-type="bibr" rid="B3">Chen et al., 2015</xref>). However, the effect of mimicked ECM microenvironment by nano-matrix scaffolds on the maturation of iPSC-CMs is still unclear. In this study, we prepared ECM nano-matrix scaffolds using electrospinning technology to mimic the natural myocardial ECM microenvironment, and explored its effect on the maturation of iPSC-CMs.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Cell Culture</title>
<p>The iPSCs carrying the GFP transgene targeted to the Oct4 locus (kindly provided by Duanqing Pei, Chinese Academy of Sciences) were cultured with basic fibroblast growth factor (Chemicon, Temecula, CA). CMs were cultured as previously report (<xref ref-type="bibr" rid="B31">Zeng et al., 2013</xref>). The iPSCs were planted on the electrospun 3D PCL at the beginning of the induction differentiation. Undifferentiated human iPSCs were cultured on a mitotically inactivated mouse embryonic fibroblast (MEF; 50,000 cells/cm2) feeder layer or on gelatin-coated dishes. Starting at day 2 of differentiation, the differentiation medium was replaced every second day.</p>
</sec>
<sec id="s2-2">
<title>Nanofibrous Scaffold Preparation by Electrospinning</title>
<p>The 3D poly-(&#x3b5;-caprolactone) (PCL) nanofibrous scaffold was fabricated using electrospinning technology based on our previously study (<xref ref-type="bibr" rid="B3">Chen et al., 2015</xref>). The schematic diagram was shown in <xref ref-type="fig" rid="F1">Figure 1A</xref>. The 3D PCL nanofibrous scaffold was fabricated by electrospinning. Briefly, pellets of PCL with an average molecular weight of 80&#xa0;kDa (Aldrich, St. Louis,MO, United States) were dissolved in a chloroform/methanol (3:1, v/v) solvent mixture at room temperature (25 &#xb1; 1&#xb0;C) to obtain a 20&#xa0;wt% solution. Then, the PCL solution was placed in a 10-ml plastic syringe connected to a bluntstainless steel needle with an inner tip diameter of 0.5&#xa0;mm. A syringe pump (PHD22/2000, Harvard Apparatus, Holliston, MA, United States) was used to control the flow rate at 2&#xa0;ml/h. A 20-kV high-voltage power supply and a distance of approximately 15&#xa0;cm were maintained between the needle and the grounded flat aluminum plate collector (size: 15 &#xd7; 15&#xa0;cm<sup>2</sup>) throughout the electrospinning process. Then, the PCL fibrous scaffolds were sterilized under ultraviolet (UV) light for 1&#xa0;h. Finally, the scaffold was precoated with gelatin (Sigma-Aldrich, St. Louis, MO, United States) by immersion in a sterilized 0.1% (1&#xa0;g/l) gelatin solution overnight.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Electrospinning was used to prepare and characterize nanofibrous scaffold. <bold>(A)</bold> Schematic diagram of electrospinning technology. <bold>(B)</bold> SEM micrographs of PCL/collagen nano-scaffold without matrigel coating. <bold>(C)</bold> SEM micrographs of PCL/collagen nano-scaffold with matrigel coating. <bold>(D)</bold> SEM micrographs of iPSCs colonies cultured on nano-scaffold at day 2. <bold>(E)</bold> SEM micrographs of iPSC-CMs colonies cultured on nano-scaffold at day 15. White arrows indicate CM-like morphology. Scale bar in <bold>(B&#x2013;C)</bold>: 2&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="fcell-10-875278-g001.tif"/>
</fig>
</sec>
<sec id="s2-3">
<title>Scanning Electron Microscopy</title>
<p>The morphology of electrospun PCL fibrous scaffolds was observed by SEM as previously described (<xref ref-type="bibr" rid="B3">Chen et al., 2015</xref>).</p>
</sec>
<sec id="s2-4">
<title>Immunocytochemistry</title>
<p>After differentiated for 15 days, the cells were fixed and incubated with primary antibodies (anti-MLC-2V, anti-&#x3b1;-actinin, anti-Ki67, anti-MHC, anti-connexin 43 (Cx43) and anti-cardiac troponin T (cTnT), 1:200, all from Abcam, Cambridge, MA, United States) for 60min at room temperature.</p>
</sec>
<sec id="s2-5">
<title>Morphological Analysis</title>
<p>The cell size and sarcomere length were analyzed using ImageJ analysis software.</p>
</sec>
<sec id="s2-6">
<title>Calcium Imaging</title>
<p>The ratiometric indicator dye Fura-4 AM was applied to measure intracellular calcium.</p>
</sec>
<sec id="s2-7">
<title>qRT-PCR</title>
<p>Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, CA, United States). PCR was performed as previously described (<xref ref-type="bibr" rid="B3">Chen et al., 2015</xref>).</p>
</sec>
<sec id="s2-8">
<title>Western Blotting</title>
<p>Total protein was extracted from cells underwent differentiation for 15 days. The primary antibodies as follows: &#x3b1;-MHC,&#x3b2;-MHC (1:1,000; Abcam, Cambridge, MA, United States), MLC2a, MLC2v (1:1,000, Santa Cruz Biotechnology, Dallas, TX, United States) and GAPDH (1:10,000; Abcam, Cambridge, MA, United States). The band intensities were quantified using ImageJ software.</p>
</sec>
<sec id="s2-9">
<title>Statistical Analysis</title>
<p>Results are presented as mean &#xb1; SEM. Data were analyzed by Student&#x2019;s t test or one-way ANOVA with repeated-measures analysis. <italic>p</italic> &#x3c; 0.05 were considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Characterization of Nanofibrous Scaffolds</title>
<p>As shown in <xref ref-type="fig" rid="F1">Figure 1A</xref>, nanofibrous scaffolds were prepared with PCL/collagen solutions using electrospinning. SEM of nanofibrous scaffolds revealed cross arrangement of nanofibers without beads, which formed a porous 3D structure (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The nanofibrous scaffolds were pre-coated with matrigel for iPSCs adhension. SEM of nanofibrous scaffolds pre-coated with matrigel revealed that the nanofibers are bridged by matrigel but remained many interconnected pores (<xref ref-type="fig" rid="F1">Figure 1C</xref>). This porous 3D structure was essential for oxygen and nutrition exchange during the CM differentiation of iPSCs.</p>
<p>Moreover, colonies of iPSCs were scattered and adhered well to the nanofibrous scaffolds during day 2 of CM differentiation (<xref ref-type="fig" rid="F1">Figure 1D</xref>). At day 15 of CM differentiation, SEM revealed that the iPSCs spontaneously differentiated into many cells with morphology similar to neonatal cardiomyocytes (NCMs, <xref ref-type="fig" rid="F1">Figure 1E</xref>). Based on above results, we conclued that the nanofibrous scaffold was a suitable three-dimensional carrier for the differentiation of iPSCs into CMs.</p>
</sec>
<sec id="s3-2">
<title>Spontaneous Cardiac Differentiation of iPSCs on 3D Nanofibrous Scaffolds</title>
<p>After the purified Oct4-GFP<sup>&#x2b;</sup> iPSCs without MEFs were seeded on the 3D nanofibrous scaffold, the expression of Oct4 was decreased during day 2 of differentiation (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Cells with morphology similar to neonatal cardiomyocytes were differentiated during day 15 of differentiation, and the immunofluorescence for cTnT indicated that the differentiated cells were iPSC-CMs. Meanwhile, the gene markers for detecting the phenotype of CM differentiation was assessed compared to NCMs and adult CMs. The expression of ANF, MLC2a and MLC2v of iPSC-CMs cultured on 3D nanofibrous scaffolds were significantly higher than that of NCMs, but slightly lower than that of adult CMs (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Moreover, double staining of the cTnT with MHC, &#x3b1;-actinin, and MLC2v showed that the iPSC-CMs with the scaffolds co-expressed the CM phenotype markers, including cTnT with MHC, &#x3b1;-actinin, and MLC2v (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Thus, the 3D nanofibrous scaffold could promote the differentiation of iPSCs into functional CMs.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>CMs was differentiated from hPSCs cultured on 3D nanofibrous scaffold. <bold>(A)</bold> Fluorescence expression of Oct4 (day 2) and cTnI (day 15) in differentiation. <bold>(B,C)</bold> RT-PCR analysis of cardiac-specific gene expression in differentiated iPSC-CMs cultured with 3D nano-scaffolds, NCMs and adult CMs. <bold>(D)</bold> Immunofluorescence co-staining of cTnT with MHC, &#x3b1;-actinin and MLC2v in cells at day 15 of differentiation on 3D nanofibrous scaffolds to identify the CM phenotype.</p>
</caption>
<graphic xlink:href="fcell-10-875278-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Nanofibrous Scaffolds Enhance Structural Maturation of iPSC-CMs</title>
<p>To clarify the effects of nanofibrous scaffolds on the iPSC-CMs, we detected the cardiac-specific structural protein such as MHC, a-actinin, cTnT (a sarcomere protein) and MLC-2v (a key protein for structural maturation) (<xref ref-type="bibr" rid="B13">Karbassi et al., 2020b</xref>). iPSC-CMs were small in shape with disordered myofibril arrangement in control group, while iPSC-CMs formed well-organized sarcomeric myofilaments in cytoplasmic patterns on nano-scaffolds (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Measurement of cell area showed that 3D nano-scaffolds culture increased the cell area by 90% (1,153 &#xb1; 145&#xa0;&#x3bc;m<sup>2</sup> vs. 2,235 &#xb1; 207&#xa0;&#x3bc;m<sup>2</sup>, <italic>p</italic> &#x3c; 0.01), indicating a more mature cardiomyocyte phenotype (<xref ref-type="fig" rid="F3">Figure 3B</xref>). Moreover, sarcomere length of iPSC-CMs was increased from 1.55 &#xb1; 0.32&#xa0;&#x3bc;m in control to 1.92 &#xb1; 0.28&#xa0;&#x3bc;m in iPSC-CMs cultured on nano-scaffolds (<italic>p</italic> &#x3c; 0.05) (<xref ref-type="fig" rid="F3">Figure 3C</xref>). The gap junctions between CMs and neighbor cells are critical to the maturation of cardiomyocytes. We subsequently explored the effect of 3D nano-scaffolds on expression of gap junction protein Cx43. The immunofluorescence co-staining of Cx43 and cTnT showed that Cx43 expression was significantly higher in iPSC-CMs cultured on nano-scaffolds than that in the control group (<xref ref-type="fig" rid="F3">Figures 3D,E</xref>). These results indicated that nanofibrous scaffolds enhances structural maturation of iPSC-CMs with mature sarcomere structures such as Z-line and T tube.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Confocal microscopy was used to evaluate the structural maturation of iPSC-CMs cultured on nanofibrous scaffold. <bold>(A)</bold> Fluorescence expression of cardiac-specific structural protein (cTnI, MHC, a-actinin and cTnT) in both control and nano-scaffold groups at day 15 of differentiation. Compared with the control group, iPSC-CMs cultured on nanofibrous scaffold exhibited significant changes in cell area <bold>(B)</bold> and sarcomere length <bold>(C)</bold>. <bold>(D,E)</bold> Immunofluorescence co-staining of cTnT with gap junction protein Cx43 in control and nano-scaffold groups and the Cx43<sup>&#x2b;</sup> fluorescence expression was quantified. Data are presented as mean &#xb1; SEM, &#x2a;<italic>p</italic> &#x3c; 0.05 vs. control.</p>
</caption>
<graphic xlink:href="fcell-10-875278-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Nanofibrous Scaffolds Enhance the Expression of Cardiac Mature Proteins</title>
<p>Mature CMs are not capable to proliferate, so the proliferation ability can be used as an indirect indicator of CMs maturation. Co-staining of proliferating cell nuclear antigen Ki-67 and sarcomeric myosin MF20 showed that the Ki-67<sup>&#x2b;</sup>/MF20<sup>&#x2b;</sup> percentage was lower in iPSC-CMs cultured on nano-scaffolds than that in iPSC-CMs in control group (<xref ref-type="fig" rid="F4">Figure 4A</xref>), suggesting more mature CM phenotype with 3D nano-scaffold culture. The sarcomere-unit components are changed as the heart develops. For example, &#x3b1;-MHC at fetal stage switches to &#x3b2;-MHC at adult stage and MLC2v expression is also considered to be a marker of CM maturity. To further confirm the mature phenotype of iPSC-CMs, the expression of &#x3b1;-MHC, &#x3b2;-MHC, MLC2a and MLC2v were detected. The expression levels of &#x3b2;-MHC and MLC2v were higher in nano-scaffold group than that in the control group and NCMs, while the expression levels of &#x3b1;-MHC and MLC2a were significantly reduced (<xref ref-type="fig" rid="F4">Figures 4B,C</xref>). Moreover, the ratio of &#x3b2;-MHC/&#x3b1;-MHC and MLC2v/MLC2a were increased when iPSC-CMs were cultured on nano-scaffolds. Both of the increased expression of cardiac mature proteins and reduced proliferation capacity indicated that 3D nano-scaffold culture enhanced the maturation of CMs derived from human PSCs (hPSCs).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Cardiac mature proteins were analyzed by different assays. <bold>(A)</bold> Co-staining of Ki-67 and MF20 to detect the proliferation ability of iPSC-CMs, and Ki-67<sup>&#x2b;</sup>/MF20<sup>&#x2b;</sup> percentage was quantified. <bold>(B)</bold> Protein expression of &#x3b1;-MHC, &#x3b2;-MHC, MLC2a, and MLC2v were assessed in control, NCMs and nano-scaffold groups. The values are normalized to the housekeeping gene GAPDH. <bold>(C)</bold> Quantification of &#x3b1;-MHC, &#x3b2;-MHC, MLC2a and MLC2v protein levels in NCMs, control and nano-scaffold groups. <bold>(D)</bold> Expression ratio of &#x3b2;-MHC/&#x3b1;-MHC and MLC2v/MLC2a as mature markers in three groups. Expression levers of each gene were normalized to GAPDH. Data are presented as mean &#xb1; SEM, &#x23;<italic>p</italic> &#x3c; 0.05 vs. control; &#x23;&#x23;<italic>p</italic> &#x3c; 0.05 vs. NCMs.</p>
</caption>
<graphic xlink:href="fcell-10-875278-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Nanofibrous Scaffolds Enhance Calcium Transient Kinetics of iPSC-CMs</title>
<p>We detected the intracellular ratiometric calcium dye Fura-4 AM to compare the calcium transient kinetics in control versus iPSC-CMs cultured on nano-scaffolds under 1-Hz electrical stimulation. The intracellular calcium transient was recorded (<xref ref-type="fig" rid="F5">Figure 5A</xref>). The calcium peak transient amplitude of iPSC-CMs was increased by nano-scaffolds culture was increased by nano-scaffolds culture (0.15 &#xb1; 0.03vs. 0.25 &#xb1; 0.04, F/F0, <italic>p</italic> &#x3c; 0.05, <xref ref-type="fig" rid="F5">Figures 5B,C</xref>). The maximal upstroke velocities were also higher in iPSC-CMs cultured on nanofibrous scaffolds. Specifically, Vmax increased more rapidly in nano-scaffolds group (2.81 &#xb1; 0.42 vs. 5.24 &#xb1; 0.53&#xa0;F/F0/s, <italic>p</italic> &#x3c; 0.05, <xref ref-type="fig" rid="F5">Figure 5D</xref>). These results indicated that iPSC-CMs exhibited the enhanced CM-specific calcium handling properties and functional maturation when cultured on nanofibrous scaffolds.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Calcium transient was assessed in iPSC-CMs cultured on nanofibrous scaffold. <bold>(A)</bold> Representative line-scan of time-lapse calcium imaging in iPSC-CMs loaded with the intracellular calcium indicator Fluo-4 AM. <bold>(B)</bold> Representative records of spontaneous calcium transient. <bold>(C)</bold> Comparison of calcium transient peak amplitude between two groups. <bold>(D)</bold> Comparison of Vmax (F/F0/s) between two groups. Data are presented as mean &#xb1; SEM, &#x2a;<italic>p</italic> &#x3c; 0.05 vs. control.</p>
</caption>
<graphic xlink:href="fcell-10-875278-g005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>iPSC-CMs are the ideal cardiomyocyte source for replacing dysfunctional CMs in the future because of the unique electrophysiological and distinctive contractile properties (<xref ref-type="bibr" rid="B19">Mummery, 2018</xref>). However, even after differentiation, iPSC-CMs retain a part of immature phenotype. There is still no better way to make these cells more mature to achieve the complicated structural and functional phenotype of CMs <italic>in vitro</italic> (<xref ref-type="bibr" rid="B32">Zhu et al., 2014</xref>). Thus, increased attempts have been made to optimize the maturation of hPSC-CMs via diverse approaches (<xref ref-type="bibr" rid="B19">Mummery, 2018</xref>; <xref ref-type="bibr" rid="B30">Yang et al., 2019</xref>). However, the early efforts to mature these cells by implanting them in the heart have been still insufficient (<xref ref-type="bibr" rid="B25">Shiba et al., 2012</xref>; <xref ref-type="bibr" rid="B4">Chong et al., 2014</xref>). 3D nano-scaffold culture has been recommended as one of the methods to optimize the differentiation efficiency of iPSC-CMs, which had been proved to promote the CM differentiation from iPSCs by our previous studies (<xref ref-type="bibr" rid="B20">Ou et al., 2013</xref>). However, it is still unclear whether 3D nano-scaffold culture is enough to reinforce the robust maturation of hPSC-CMs. In this research, we synthesized nanofibrous scaffolds with PCL/collage components to simulate the matrix microenvironment of myocardial maturation, and evaluated the efficacy of these scaffolds on the maturation of iPSC-CMs. As expected, iPSC-CMs on nanofibrous scaffolds preferentially differentiated to mature CMs. The difference with the cells on TCP is that the iPSC-CMs on nanofibrous scaffolds significantly enhanced structural maturation with increased levels of cardiac-specific proteins and well-organized sarcomeric myofilaments. Moreover, calcium transient kinetics of iPSC-CMs were promoted by nanofibrous scaffolds, proposing that the functional maturation of iPSC-CMs was optimized by nanofibrous scaffolds.</p>
<p>In contrast to adult CMs, iPSC-CMs under normal culture fail to generate the characteristic sarcolemma invaginations (<xref ref-type="bibr" rid="B6">Gherghiceanu et al., 2011</xref>). The absence of the regular cell structure with disorganized distribution of myofibrils leads to discordant contraction. Differentiation and growth of iPSC-CM monolayers is prevalent due to the simplicity and moderate scalability of this approach for CM generation. The heart is a 3D organ structure which favors the development of the heart because CMs can remain natural contact with neighboring cells. However, the extracellular matrix is improbable to occur in the 2D environment of standard cell culture (<xref ref-type="bibr" rid="B14">Kshitiz Park et al., 2012</xref>). As a result, more and more investigators optimized the <italic>in vitro</italic> microenvironment to better reproduce the <italic>in vivo</italic> myocardium environment. The biophysical features of fibrous ECM, for example, its geometric/topographical characteristics at the nanoscale level and the transmission of biophysical factors to the cell, are vital for cardiomyocyte function and destiny decisions (<xref ref-type="bibr" rid="B11">Huebsch et al., 2010</xref>; <xref ref-type="bibr" rid="B33">Zuppinger, 2016</xref>). Our previous studies had proven the advantages of culturing iPSC-CMs in 3D systems (fibrous ECM) to enhance the differentiation efficiency of iPSC-CMs (<xref ref-type="bibr" rid="B3">Chen et al., 2015</xref>). Fibrous ECM nano-scaffolds which provide not only the ECM microenvironment but also 3D architecture for cardiac development. We hypothesized that the fibrous ECM nano-scaffolds could facilitate iPSC-CMs towards more mature phenotype. Previous studies reported that polymeric scaffolds comprising different ECM components promoted the differentiation of hiPSCs to functional CMs (<xref ref-type="bibr" rid="B7">Gupta et al., 2011</xref>; <xref ref-type="bibr" rid="B16">Lemoine et al., 2017</xref>; <xref ref-type="bibr" rid="B27">Ulmer et al., 2018</xref>). However, cells were pretreated with Noggin in previous study, which made it difficult to decipher the cardiogenesis effect on these scaffolds. To validate the direct effect of 3D nanofibrous scaffolds on the maturation of CM derived from iPSCs, we directly seeded iPSCs on nanofibrous scaffolds without any additional factors or modulators through the monolayer approach. In our research, the biophysical signals of the 3D nanofibrous scaffolds could facilitate the structural maturation of iPSC-CMs, including the morphology, sarcomeres, and gap junction.</p>
<p>A characteristic sign of iPSC-CMs immaturity is their spontaneous beating behavior resulting from spontaneous depolarizations and contraction due to calcium transients. Mature cardiomyocyte morphology not only supplies the constructure framework but also directly sets other key functional properties such as electrophysiology and contractility. Therefore, we hypothesized that fibrous ECM nano-scaffolds could also enhance the functional maturation due to the enhancement effect on structural maturation of iPSC-CMs. The exact underlying mechanisms of automaticity and contractility may include immature calcium handling, which might be relevant to the expression of premature protein isoforms which were involved in regulation of calcium homeostasis (<xref ref-type="bibr" rid="B17">Lipskaia et al., 2014</xref>). Our results revealed that the calcium peak transient amplitude and Vmax of iPSC-CMs were increased by 3D nanofibrous scaffolds, which indicated more mature calcium transient kinetics. Our data also demonstrated that the induced elongated cell shape had a dramatic effect on cell microstructure, distribution patterns, membrane properties, and protein expression, which resulted in strong calcium handling during spontaneous and triggered activity. Therefore, we suggest that tight control of 3D architecture can induce structural and functional maturation development in iPSC-CMs.</p>
<p>The elaboration of maturation mechanisms in CM remain incomplete. In addition, an unified definition of maturation is still absent. Regarding cardiac development, multiple factors including biophysical, biochemical or biological cues may influence cardiomyocyte maturation. Accordingly, previous studies have involved molecular targets, genetic manipulation methods, and cell co-culture or implantation to induce further maturation of iPSC-CMs, especially in structural or functional properties (<xref ref-type="bibr" rid="B1">Abilez et al., 2017</xref>; <xref ref-type="bibr" rid="B26">Sun and Nunes, 2017</xref>). However, these strategies are difficult to better recapitulate the <italic>in vivo</italic> myocardium environment. There are still some challenges and difficulties in facilitating the maturation of iPSC-CMs <italic>in vitro</italic>. First, iPSC-CMs are considerably distinguished from adult human ventricular CMs, as shown in the present study. For instance, the sarcomere length of relaxed human cardiac muscle cell is about 2.8&#xa0;&#x3bc;m (<xref ref-type="bibr" rid="B2">Bird et al., 2003</xref>), which is approximately 1.5 times the value of hPSC-CMs observed in this study. It can take 6,7&#xa0;years for human CMs to achieve some of the characteristics of adult CMs <italic>in vivo</italic> (<xref ref-type="bibr" rid="B22">Peters et al., 1994</xref>), indicating the essential need of accelerated maturation for iPSC-CMs differentiated <italic>in vitro</italic>. Secondly, most studies so far, including our present research, have used heterogeneous iPSC-CM population. Heterogeneous maturation levels include immature embryonic or neonatal-like CMs, which are refiected in different levels of maturation in sarcomeric organizations and electrophysiological characteristics (<xref ref-type="bibr" rid="B29">Yang et al., 2014</xref>; <xref ref-type="bibr" rid="B28">Veerman et al., 2015</xref>). We speculated that our electrospun fibers prepared with PCL/collagen and matrigel could recapitulate 3D nano-scaffolding environment for cardiac development and maturation. In future studies, the fiber size/scaffold topology can be optimized by modulating the electrospinning parameters (<xref ref-type="bibr" rid="B8">Han et al., 2013</xref>) to facilitate the cell spreading and maturation (<xref ref-type="bibr" rid="B15">Kuroda et al., 2014</xref>). In addition, a stage-specific dynamic design of the fiber size/scaffold topology may be more advantageous, as iPSC-CMs constantly enlarge during maturation.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>In summary, our study confirmed that the artificial 3D nanofibrous scaffold is an excellent substrate for the maturation of iPSC-CMs. The study also identified that 3D nanofibrous scaffolds could directly facilitate the structural and functional maturation of iPSC-CMs, which was arguably an optimal method to promote maturation <italic>in vitro</italic>. Our findings presented new perspectives on novel biomimetic scaffolds to guide the efficient maturation of iPSCs for future myocardial tissue engineering and regenerative medicine.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>DZ and MZ defined the topic of this project and revised the manuscript carefully. MZ, YX, YC, and QY performed the laboratory experiments and wrote the manuscript. XL, LD, and TW analyzed the data. All authors carried out the work, read, and approved the final manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This study was supported by grants from the National Natural Science Foundation of China (No.31400832, No. 81070161, and No. 81900338). We thank Duanqing Pei from Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences (GIBH) for providing hPSCs.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abilez</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Tzatzalos</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.-T.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Z&#xf6;llner</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling</article-title>. <source>Stem Cells</source> <volume>36</volume>, <fpage>265</fpage>&#x2013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1002/stem.2732</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bird</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Doevendans</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>van Rooijen</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Brutel de la Riviere</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hassink</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Passier</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>The Human Adult Cardiomyocyte Phenotype</article-title>. <source>Cardiovasc. Res.</source> <volume>58</volume>, <fpage>423</fpage>&#x2013;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1016/s0008-6363(03)00253-0</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.-L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.-T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.-J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Three-dimensional Poly-(&#x3b5;-Caprolactone) Nanofibrous Scaffolds Directly Promote the Cardiomyocyte Differentiation of Murine-Induced Pluripotent Stem Cells through Wnt/&#x3b2;-Catenin Signaling</article-title>. <source>BMC Cell Biol.</source> <volume>16</volume>, <fpage>22</fpage>. <pub-id pub-id-type="doi">10.1186/s12860-015-0067-3</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname>
<given-names>J. J. H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Don</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Minami</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.-W.</given-names>
</name>
<name>
<surname>Weyers</surname>
<given-names>J. J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Human Embryonic-Stem-Cell-Derived Cardiomyocytes Regenerate Non-human Primate Hearts</article-title>. <source>Nature</source> <volume>510</volume>, <fpage>273</fpage>&#x2013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1038/nature13233</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feaster</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Cadar</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>Y. W.</given-names>
</name>
<name>
<surname>Hempel</surname>
<given-names>J. E.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Matrigel Mattress</article-title>. <source>Circ. Res.</source> <volume>117</volume>, <fpage>995</fpage>&#x2013;<lpage>1000</lpage>. <pub-id pub-id-type="doi">10.1161/circresaha.115.307580</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gherghiceanu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barad</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Novak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Itskovitz-Eldor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Binah</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Cardiomyocytes Derived from Human Embryonic and Induced Pluripotent Stem Cells: Comparative Ultrastructure</article-title>. <source>J. Cell Mol. Med.</source> <volume>15</volume>, <fpage>2539</fpage>&#x2013;<lpage>2551</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2011.01417.x</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Walthall</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Venkataraman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Crowder</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S. S.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Combinatorial Polymer Electrospun Matrices Promote Physiologically-Relevant Cardiomyogenic Stem Cell Differentiation</article-title>. <source>PLoS One</source> <volume>6</volume> (<issue>12</issue>), <fpage>e28935</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0028935</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gerstenhaber</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Lazarovici</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lelkes</surname>
<given-names>P. I.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Tissue Factor Activity and ECM-Related Gene Expression in Human Aortic Endothelial Cells Grown on Electrospun Biohybrid Scaffolds</article-title>. <source>Biomacromolecules</source> <volume>14</volume> (<issue>5</issue>), <fpage>1338</fpage>&#x2013;<lpage>1348</lpage>. <pub-id pub-id-type="doi">10.1021/bm400450m</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herron</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>K. F.</given-names>
</name>
<name>
<surname>Ponce-Balbuena</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Willis</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Guerrero-Serna</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function</article-title>. <source>Circ. Arrhythm. Electrophysiol.</source> <volume>9</volume>, <fpage>e003638</fpage>. <pub-id pub-id-type="doi">10.1161/circep.113.003638</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Peres Moreno Maia-Joca</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>DiSilvestre</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tomaselli</surname>
<given-names>G. F.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Enhancement of Human iPSC-Derived Cardiomyocyte Maturation by Chemical Conditioning in a 3D Environment</article-title>. <source>J. Mol. Cell. Cardiol.</source> <volume>138</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2019.10.001</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huebsch</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Arany</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Shvartsman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Bencherif</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Harnessing Traction-Mediated Manipulation of the Cell/matrix Interface to Control Stem-Cell Fate</article-title>. <source>Nat. Mater</source> <volume>9</volume> (<issue>6</issue>), <fpage>518</fpage>&#x2013;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1038/nmat2732</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karbassi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fenix</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marchiano</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Muraoka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cardiomyocyte Maturation: Advances in Knowledge and Implications for Regenerative Medicine</article-title>. <source>Nat. Rev. Cardiol.</source> <volume>17</volume>, <fpage>341</fpage>&#x2013;<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-019-0331-x</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karbassi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fenix</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marchiano</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Muraoka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cardiomyocyte Maturation: Advances in Knowledge and Implications for Regenerative Medicine</article-title>. <source>Nat. Rev. Cardiol.</source> <volume>17</volume> (<issue>6</issue>), <fpage>341</fpage>&#x2013;<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-019-0331-x</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kshitiz Park</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Helen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Engler</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Levchenko</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Control of Stem Cell Fate and Function by Engineering Physical Microenvironments</article-title>. <source>Integr. Biol. (Camb).</source> <volume>4</volume> (<issue>9</issue>), <fpage>1008</fpage>&#x2013;<lpage>1018</lpage>. <pub-id pub-id-type="doi">10.1039/c2ib20080e</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yasuda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>
<italic>In Vitro</italic> detection of Residual Undifferentiated Cells in Retinal Pigment Epithelial Cells Derived from Human Induced Pluripotent Stem Cells</article-title>. <source>Methods Mol. Biol.</source> <volume>1210</volume>, <fpage>183</fpage>&#x2013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-1435-7_14</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemoine</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Mannhardt</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Breckwoldt</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Prondzynski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Flenner</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ulmer</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Human iPSC-Derived Cardiomyocytes Cultured in 3D Engineered Heart Tissue Show Physiological Upstroke Velocity and Sodium Current Density</article-title>. <source>Sci. Rep.</source> <volume>7</volume> (<issue>1</issue>), <fpage>5464</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-05600-w</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipskaia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Keuylian</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Blirando</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mougenot</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jacquet</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rouxel</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Expression of Sarco (Endo) Plasmic Reticulum Calcium ATPase (SERCA) System in Normal Mouse Cardiovascular Tissues, Heart Failure and Atherosclerosis</article-title>. <source>Biochimica Biophysica Acta (BBA) - Mol. Cell Res.</source> <volume>1843</volume>, <fpage>2705</fpage>&#x2013;<lpage>2718</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.08.002</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.-W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fugate</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Kalucki</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Futakuchi-Tsuchida</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Human Embryonic Stem Cell-Derived Cardiomyocytes Restore Function in Infarcted Hearts of Non-human Primates</article-title>. <source>Nat. Biotechnol.</source> <volume>36</volume>, <fpage>597</fpage>&#x2013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.4162</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mummery</surname>
<given-names>C. L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research</article-title>. <source>Stem Cell Rep.</source> <volume>11</volume> (<issue>6</issue>), <fpage>1306</fpage>&#x2013;<lpage>1311</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2018.11.011</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ou</surname>
<given-names>D.-B.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.-T.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>J.-W.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>W.-G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>The Long-Term Differentiation of Embryonic Stem Cells into Cardiomyocytes: An Indirect Co-culture Model</article-title>. <source>PLoS One</source> <volume>8</volume> (<issue>1</issue>), <fpage>e55233</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0055233</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parikh</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Blackwell</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Gomez-Hurtado</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Frisk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes</article-title>. <source>Circ. Res.</source> <volume>121</volume>, <fpage>1323</fpage>&#x2013;<lpage>1330</lpage>. <pub-id pub-id-type="doi">10.1161/circresaha.117.311920</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Severs</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Rothery</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Lincoln</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yacoub</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>C. R.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Spatiotemporal Relation between Gap Junctions and Fascia Adherens Junctions during Postnatal Development of Human Ventricular Myocardium</article-title>. <source>Circulation</source> <volume>90</volume> (<issue>2</issue>), <fpage>713</fpage>&#x2013;<lpage>725</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.90.2.713</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ronaldson-Bouchard</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Yeager</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sirabella</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Advanced Maturation of Human Cardiac Tissue Grown from Pluripotent Stem Cells</article-title>. <source>Nature</source> <volume>556</volume>, <fpage>239</fpage>&#x2013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0016-3</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sartiani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bettiol</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stillitano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mugelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cerbai</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jaconi</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Developmental Changes in Cardiomyocytes Differentiated from Human Embryonic Stem Cells: a Molecular and Electrophysiological Approach</article-title>. <source>Stem Cells</source> <volume>25</volume>, <fpage>1136</fpage>&#x2013;<lpage>1144</lpage>. <pub-id pub-id-type="doi">10.1634/stemcells.2006-0466</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shiba</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.-Z.</given-names>
</name>
<name>
<surname>Filice</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Muskheli</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Human ES-Cell-Derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts</article-title>. <source>Nature</source> <volume>489</volume>, <fpage>322</fpage>&#x2013;<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1038/nature11317</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Nunes</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Bioengineering Approaches to Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>5</volume>, <fpage>19</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2017.00019</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulmer</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Stoehr</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gucek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mannhardt</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes</article-title>. <source>Stem Cell Rep.</source> <volume>10</volume> (<issue>3</issue>), <fpage>834</fpage>&#x2013;<lpage>847</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2018.01.039</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veerman</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Kosmidis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mummery</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Casini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Verkerk</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Bellin</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?</article-title> <source>Stem Cells Dev.</source> <volume>24</volume> (<issue>9</issue>), <fpage>1035</fpage>&#x2013;<lpage>1052</lpage>. <pub-id pub-id-type="doi">10.1089/scd.2014.0533</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Pabon</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Murry</surname>
<given-names>C. E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Engineering Adolescence</article-title>. <source>Circ. Res.</source> <volume>114</volume> (<issue>3</issue>), <fpage>511</fpage>&#x2013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1161/circresaha.114.300558</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Fatty Acids Enhance the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells</article-title>. <source>Stem Cell Rep.</source> <volume>13</volume> (<issue>4</issue>), <fpage>657</fpage>&#x2013;<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2019.08.013</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>D.-B.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.-T.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.-L.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Collagen/&#x3b2;1 Integrin Interaction Is Required for Embryoid Body Formation during Cardiogenesis from Murine Induced Pluripotent Stem Cells</article-title>. <source>BMC Cell Biol.</source> <volume>25</volume>, <fpage>5</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2121-14-5</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Blazeski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>K. D.</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Boheler</surname>
<given-names>K. R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Physical Developmental Cues for the Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes</article-title>. <source>Stem Cell Res. Ther.</source> <volume>5</volume>, <fpage>117</fpage>. <pub-id pub-id-type="doi">10.1186/scrt507</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuppinger</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>3D Culture for Cardiac Cells</article-title>. <source>Biochimica Biophysica Acta (BBA) - Mol. Cell Res.</source> <volume>1863</volume>, <fpage>1873</fpage>&#x2013;<lpage>1881</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2015.11.036</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>